Location History:
- Rockville, MD (US) (2019)
- Los Angeles, CA (US) (2021)
- Gaithersburg, MD (US) (2020 - 2022)
Company Filing History:
4 out of 3,539 
1 out of 1,929 
1 out of 1,285 
Years Active: 2019-2022
Title: Patricia Dranchak: Innovator in Cancer Research and Therapeutics
Introduction
Patricia Dranchak is a distinguished inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of cancer research and therapeutics, holding a total of 5 patents. Her work focuses on innovative methods to address critical health issues, particularly in cancer treatment and the management of pruritus.
Latest Patents
Dranchak's latest patents include a groundbreaking method for identifying compounds that affect the multienzyme metabolic assembly of glucose metabolism and its association with cell cycle progression in cancer cells. This patent describes a cell-based quantitative high-throughput screening assay designed to monitor the formation of PFK1-mEGFP clusters. The goal is to identify small molecules that promote intracellular PFK1 clustering in a cell cycle-dependent manner, which may be utilized in cancer treatment. Another notable patent involves compositions and methods for the inhibition of pruritus. This patent discloses pharmaceutical compositions comprising a molecular inhibitor of Npr1, along with methods for treating, reducing, or preventing acute and chronic pruritus in mammals.
Career Highlights
Throughout her career, Dranchak has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the University System of Maryland. Her work in these institutions has allowed her to advance her research and contribute to significant scientific discoveries.
Collaborations
Dranchak has collaborated with notable colleagues, including James Inglese and Mark A. Hoon. These partnerships have further enriched her research and innovation in the field.
Conclusion
Patricia Dranchak's contributions to cancer research and therapeutics exemplify her dedication to improving health outcomes through innovation. Her patents reflect her commitment to addressing complex medical challenges, making her a prominent figure in her field.